Bashar Hamad
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cardiac Arrhythmias and Treatments 3
- Atrial Fibrillation Management and Outcomes 3
- Cardiac electrophysiology and arrhythmias 2
- Antiplatelet Therapy and Cardiovascular Diseases 2
-
- Pharmaceutical Economics and Policy 3
- Co-authors
- Peter Kirkpatrick (4 shared papers)Xiaoxiao Qian (1 shared paper)Kurt Huber (2 shared papers)Uma Yasothan (2 shared papers)Basharut A. Syed (2 shared papers)Rami A. Al‐Horani (2 shared papers)Jalal K. Ghali (1 shared paper)Peter J. Kirkpatrick (1 shared paper)
- Partner nations
- United KingdomUnited StatesAustria
In The Last Decade
Bashar Hamad
16 papers receiving 506 citations
Peers
Comparison fields: 5 of 96
- Molecular Medicine 69
- Applied Microbiology and Biotechnology 15
- Pharmacology 92
- Pollution 55
- Internal Medicine 12
Countries citing papers authored by Bashar Hamad
This map shows the geographic impact of Bashar Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bashar Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bashar Hamad more than expected).
Fields of papers citing papers by Bashar Hamad
This network shows the impact of papers produced by Bashar Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bashar Hamad. The network helps show where Bashar Hamad may publish in the future.
Co-authors
The 13 scholars most cited alongside Bashar Hamad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 235 | |
| 2 | 2015 | 47 | |
| 3 | 2009 | 28 | |
| 4 | 2014 | 28 | |
| 5 | 2011 | 27 | |
| 6 | 2019 | 24 | |
| 7 | 2021 | 22 | |
| 8 | 2016 | 19 | |
| 9 | 2009 | 18 | |
| 10 | 2017 | 16 | |
| 11 | 2010 | 16 | |
| 12 | 2018 | 13 | |
| 13 | 2009 | 13 | |
| 14 | 2014 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2015 | 4 | |
| 17 | 2025 | 0 |
About Bashar Hamad
Bashar Hamad is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics, Pharmacology, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 17 papers that have together received 520 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (3 papers), Cardiac Arrhythmias and Treatments (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Pharmaceutical Economics and Policy (3 papers), Cardiac electrophysiology and arrhythmias (2 papers), Inflammatory mediators and NSAID effects (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Allergic Rhinitis and Sensitization (1 paper). The work is most often cited by research in Molecular Medicine (69 citations), Applied Microbiology and Biotechnology (15 citations), Pharmacology (92 citations), Pollution (55 citations) and Internal Medicine (12 citations). Bashar Hamad has collaborated with scholars based in United Kingdom, United States and Austria. Frequent co-authors include Peter Kirkpatrick, Xiaoxiao Qian, Kurt Huber, Uma Yasothan, Basharut A. Syed, Rami A. Al‐Horani, Jalal K. Ghali, Peter J. Kirkpatrick, Ian Sander and Dobromir Dobrev. Their work appears in journals such as Nature Reviews Drug Discovery and Hospital Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.